Literature DB >> 11306513

Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.

D J Price1, T Miralem, S Jiang, R Steinberg, H Avraham.   

Abstract

The expression of vascular endothelial growth factor (VEGF) by breast tumors has been previously correlated with a poor prognosis in the pathogenesis of breast cancer. Furthermore, VEGF secretion is a prerequisite for tumor development. Although most of the effects of VEGF have been shown to be attributable to the stimulation of endothelial cells, we present evidence here that breast tumor cells are capable of responding to VEGF. We show that VEGF stimulation of T-47D breast cancer cells leads to changes in cellular signaling and invasion. VEGF increases the cellular invasion of T-47D breast cancer cells on Matrigel/ fibronectin-coated transwell membranes by a factor of two. Northern analysis for the expression of the known VEGF receptors shows the presence of moderate levels of Flt-1 and low levels of Flk-1/KDR mRNAs in a variety of breast cancer cell lines. T-47D breast cancer cells bind 125I-labeled VEGF with a Kd of 13 x 10(-9) M. VEGF induces the activation of the extracellular regulated kinases 1,2 as well as activation of phosphatidylinositol 3'-kinase, Akt, and Forkhead receptor L1. These findings in T-47D breast cancer cells strongly suggest an autocrine role for VEGF contributing to the tumorigenic phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306513

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  54 in total

1.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

Authors:  P I Imoukhuede; Aleksander S Popel
Journal:  Exp Cell Res       Date:  2010-12-23       Impact factor: 3.905

2.  Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells.

Authors:  Rebecca A Stein; Stéphanie Gaillard; Donald P McDonnell
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03-03       Impact factor: 4.292

Review 3.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

4.  VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.

Authors:  Tao Li; Yuhua Zhu; Lihui Han; Wanhua Ren; Hui Liu; Chengyong Qin
Journal:  Future Oncol       Date:  2015-11-09       Impact factor: 3.404

5.  The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.

Authors:  Hamid Gharaee; Mohammad Reza Shayegan; Mohammad Reza Khakzad; Sina Kianoush; A-Reza Varasteh; Mojtaba Sankian; Mojtaba Meshkat
Journal:  Int Ophthalmol       Date:  2014-10-26       Impact factor: 2.031

6.  SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.

Authors:  Emily Young; Lucio Miele; Kevan B Tucker; Min Huang; Jeremy Wells; Jian-Wei Gu
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

7.  Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.

Authors:  Sunitha V Bachawal; Kristin C Jensen; Amelie M Lutz; Sanjiv S Gambhir; Francois Tranquart; Lu Tian; Jürgen K Willmann
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701

Review 8.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

9.  Functional significance of vascular endothelial growth factor receptor expression on human glioma cells.

Authors:  Rolf Mentlein; Frauke Forstreuter; Hubertus M Mehdorn; Janka Held-Feindt
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models.

Authors:  Carolina Salvador; Bing Li; Richard Hansen; Daniel E Cramer; Maiying Kong; Jun Yan
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.